And in a New England Journal of Medicine study, adults on the drug dropped 489% more weight than those who received placebo injections
[11] Ipamorelin was also evaluated in a randomized, double-blind, placebo-controlled phase 2 study in patients undergoing bowel resection (Beck et al., Ipamorelin 201 Study Group, 2014)
Related solutions Grow your brand, now and through patent expiry Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance
Follow the AAOS on Facebook, X, LinkedIn, and Instagram
These drugs, originally developed to manage diabetes, have gained significant attention for their weight loss benefits